Risk Factors for Bullous Pemphigoid in the Elderly: A Prospective Case–Control Study

Sylvie Bastuji‐Garin, P. Joly, Pauline Lemordant, +12

Journal of Investigative Dermatology

GeriatricsBullous PemphigoidPublic HealthRisk FactorsEpidemiology +1

A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study

P. Joly, Jean‐Claude Roujeau, Jacques Bénichou, +26

Journal of Investigative Dermatology

Bullous PemphigoidClinical DermatologyDermatologyTopical CorticosteroidsDermatopathology +2

High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma

J. Zaragoza, Agnès Caille, N. Bénéton, +4

British Journal of Dermatology

Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: A study of 28 patients

M. Lecouflet, Christophe Leux, M. Fenot, +2

Journal of the American Academy of Dermatology

AllergyPrimary Palmar HyperhidrosisEfficacy IncreasesDermatologyScleroderma +1

Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study

A. Du‐Thanh, S. Merlet, H. Maillard, +8

British Journal of Dermatology

Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients With Calcific Uremic Arteriolopathy

Hester Colboc, Philippe Moguelet, Dominique Bazin, +17

JAMA Dermatology

Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases

C. Phan, M.‐L. Sigal, M. Lhafa, +17

Annales de Dermatologie et de Vénéréologie

HypertensionPsoriasis PatientsMedicineMetabolic ComorbiditiesClinical Epidemiology +6

Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross‐sectional study

E. Mahé, Z. Reguiaï, H. Barthélémy, +13

Journal of the European Academy of Dermatology and Venereology

Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study

Julien Sénéschal, Alexandra Duplaine, H. Maillard, +6

Journal of Investigative Dermatology

OphthalmologyFacial VitiligoTacrolimus 0.1Vehicle-controlled StudyDermatology +1

The analgesic effect of electrostimulation (<scp>WoundEL</scp>^®) in the treatment of leg ulcers

Pauline Leloup, Pascal Toussaint, Jean‐Paul Lembelembe, +2

International Wound Journal

Pain TherapyPain DisordersPain MedicineSurgeryNumerical Rating Scale +21